April 16th 2025
The executive order targets lower drug prices through Medicare reforms, anticompetitive crackdowns, and transparency mandates.
Healthcare Spending Slowdown Disproportionately Affected Middle-Income, Poor
July 30th 2016The most recent pattern of healthcare spending among Americans appears to show a divergence of expenditures trends for the wealthy, middle class, and poor, which suggests a redistribution of care toward wealthier Americans.
Read More
This Week in Managed Care: July 30, 2016
July 30th 2016This week, the top stories in managed care included the release of Medicare's Star ratings for hospital quality, a new proposal from CMS to require bundled payments for cardiac care, and an FDA panel recommended approving a continuous glucose monitoring system for dosing insulin.
Watch
What We're Reading: UnitedHealth, Aetna Plan to Join California's Medicaid Program
July 27th 2016What we're reading, July 27, 2016: UnitedHealth and Aetna are looking to join California's Medicaid program; the World Health Organization is considering removing transgender identity from list of mental disorders; and medical schools rethink how to treat addiction.
Read More
Getting Medicare Prescription Drug Plans to Consider Long-Term Outcomes
July 26th 2016A new review of Medicare prescription drug plans suggests that these plans need incentives that will push them to consider long-term outcomes and costs because they tend to consider only short-term clinical outcomes and costs related only to the pharmacy benefit.
Read More
Looking for a Breakthrough in Alzheimer's as Boomers Age
July 26th 2016Presented by The Atlantic at the Democratic National Convention, the forum saw members of Congress, a scientist, and a patient all call for more prevention and early intervention in a disease that could swamp the federal budget by 2050.
Read More
Urban Institute Projects a Reduction in National Health Spending Between 2014 and 2019
July 21st 2016The update of the Urban Institute’s 2015 analysis suggests that the nation continues to be on track to spend much less on healthcare over the next several years than was projected by CMS in late 2010.
Read More
Cancer Drug Prices Follow a Sharp Upward Trajectory Post Launch
July 20th 2016A study presented at the annual meeting of the American Society of Clinical Oncology by a group from Israel that evaluated the price trend of 30 anticancer agents following their launch, found that prices may increase by as much as 44% even after adjusting for inflation.
Read More